Well-differentiated follicular patterned tumors of the thyroid with high-grade features can metastasize in the absence of capsular or vascular invasion: Report of a case

International Journal of Surgical Pathology

Volumn 22, Issue 8, 2014, Pages 749-756

  Bongiovanni, Massimo ^a   Mazzucchelli, Luca ^a   Giovanella, Luca ^b   Frattini, Milo ^a   Pusztaszeri, Marc ^c  

^a INSTITUTE OF PATHOLOGY   (Switzerland)

^b REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^c HUG ^*  (Switzerland)

Author keywords

follicular patterned lesion; noninvasive encapsulated follicular tumor; poorly differentiated thyroid carcinoma; preinvasive; thyroid

Indexed keywords

MOLECULAR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CASE REPORT; DIFFERENTIATED THYROID CANCER; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL METASTASIS; MALE; MIDDLE AGED; MITOSIS; POORLY DIFFERENTIATED THYROID CANCER; RECURRENCE RISK; THYROIDECTOMY; TUMOR NECROSIS; ADENOCARCINOMA; BONE TUMOR; PATHOLOGY; SECONDARY; THYROID GLAND; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; BONE NEOPLASMS; HUMANS; MALE; MIDDLE AGED; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84916214672     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896914531814     Document Type: Article

References (44)

1. Ghossein R. Encapsulated malignant follicular cell-derived thyroid tumors. Endocr Pathol. 2010 ; 21: 212-218
2. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria and Explanatory Notes. Ali SZ Cibas ES, ed. New York, NY: Springer ; 2010 :
3. Sobrinho Simões M, Asa SL, Kroll TG Pathology and Genetics of Tumours of Endocrine Organs. DeLellis RA Lloyd RV Heitz PU Eng C, ed. Lyon, France: IARC Press ; 67-72.
4. Hirokawa M, Carney JA, Goellner JR, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol. 2002 ; 26: 1508-1514
5. Elsheikh TM, Asa SL, Chan JK, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol. 2008 ; 130: 736-744
6. Borget I, Vielh P, Leboulleux S, et al. Assessment of the cost of fine-needle aspiration cytology as a diagnostic tool in patients with thyroid nodules. Am J Clin Pathol. 2008 ; 129: 763-771
7. Franc B, de la Salmonière P, Lange F, et al. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum Pathol. 2003 ; 34: 1092-1100
8. Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004 ; 28: 1336-1340
9. Kakudo K, Bai Y, Liu Z, Ozaki T. Encapsulated papillary thyroid carcinoma, follicular variant: a misnomer. Pathol Int. 2012 ; 62: 155-160
10. Rossi ED, Straccia P, Palumbo M, et al. Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas. Appl Immunohistochem Mol Morphol. 2013 ; 21: 237-241
11. Sethi K, Sarkar S, Das S, et al. Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma. J Exp Ther Oncol. 2011 ; 9: 187-199
12. Abbosh PH, Nephew KP. Multiple signaling pathways converge on beta-catenin in thyroid cancer. Thyroid. 2005 ; 15: 551-561
13. Wang S, Lloyd RV, Hutzler MJ, Safran MS, Patwardhan NA, Khan A. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Mod Pathol. 2000 ; 13: 882-887
14. Basolo F, Caligo MA, Pinchera A, et al. Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index. Thyroid. 2000 ; 10: 741-746
15. Tzen CY, Huang YW, Fu YS. Is atypical follicular adenoma of the thyroid a preinvasive malignancy?. Hum Pathol. 2003 ; 34: 666-669
16. Di Nicolantonio F, Martini M, Molinari F, et al. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol. 2008 ; 26: 5705-5712
17. Frattini M, Ferrario C, Bressan P, et al. Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer. Oncogene. 2004 ; 23: 7436-7440
18. Frattini M, Saletti P, Romagnani E, et al. PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients. Br J Cancer. 2007 ; 97: 1139-1145
19. Algeciras-Schimnich A, Milosevic D, McIver B, et al. Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis. Clin Chem. 2010 ; 56: 391-398
20. Sadow PM, Faquin WC. Poorly differentiated thyroid carcinoma: an incubating entity. Front Endocrinol (Lausanne). 2012 ; 3: 77
21. Chetty R. Follicular patterned lesions of the thyroid gland: a practical algorithmic approach. J Clin Pathol. 2011 ; 64: 737-741
22. Ghossein R. Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin. Arch Pathol Lab Med. 2009 ; 133: 683-691
23. LiVolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol. 2004 ; 11: 279-287
24. Autelitano F, Spagnoli LG, Santeusanio G, Villaschi S, Autelitano M. Critical reflections on differentiated carcinoma of the thyroid: difficulties, doubts and differential-diagnosis problems. Ann Ital Chir. 1989 ; 60: 267-280
25. Lang W, Georgii A, Stauch G, Kienzle E. The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland. Virchows Arch A Pathol Anat Histol. 1980 ; 385: 125-141
26. Rivera M, Ricarte-Filho J, Patel S, et al. Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol. 2010 ; 41: 172-180
27. Hazard JB, Kenyon R. Atypical adenoma of the thyroid. AMA Arch Pathol. 1954 ; 58: 554-563
28. Vasko VV, Gaudart J, Allasia C, et al. Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma. Eur J Endocrinol. 2004 ; 151: 779-786
29. Rosai J. Handling of thyroid follicular patterned lesions. Endocr Pathol. 2005 ; 16: 279-283
30. Evans HL. Follicular neoplasms of the thyroid: a study of 44 cases followed for a minimum of 10 years, with emphasis on differential diagnosis. Cancer. 1989 ; 54: 535-540
31. Williams E, Abrosimov A, Bogdanova T. Two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol. 2000 ; 8: 181-183
32. Piana S, Frasoldati A, Di Felice E, Gardini G, Tallini G, Rosai J. Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma. Am J Surg Pathol. 2010 ; 34: 868-872
33. Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 2001 ; 91: 505-524
34. Baloch ZW, LiVolsi VA. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol. 2000 ; 13: 861-865
35. Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer. 2008 ; 113: 48-56
36. Bongiovanni M, Bloom L, Krane JF, et al. Cytomorphologic features of poorly differentiated thyroid carcinoma: a multi-institutional analysis of 40 cases. Cancer Cytopathol. 2009 ; 117: 185-194
37. Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007 ; 31: 1256-1264
38. Albores-Saavedra J, Carrick K. Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid. Endocr Pathol. 2004 ; 15: 297-305
39. Ghossein RA, Rosai J, Heffess C. Dyshormonogenetic goiter: a clinicopathologic study of 56 cases. Endocr Pathol. 1997 ; 8: 283-292
40. Volante M, Rapa I, Papotti M. Poorly differentiated thyroid carcinoma: diagnostic features and controversial issues. Endocr Pathol. 2008 ; 9: 150-155
41. Sobrinho Simões M, Albores-Saavedra J, Tallini G Pathology and Genetics of Tumours of Endocrine Organs. DeLellis R Lloyd R Heitz P Eng C, ed. Lyon, France: IARC Press ; 73-76.
42. Rufini V, Salvatori M, Fadda G, et al. Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns. Cancer. 2007 ; 110: 1209-1217
43. Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol. 1999 ; 23: 205-211
44. Dettmer M, Schmitt A, Steinert H, et al. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?. Am J Surg Pathol. 2011 ; 35: 1866-1872